Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Merck
McKesson
Dow
Mallinckrodt

Last Updated: August 19, 2022

Investigational Drug Information for Hydronidone


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Hydronidone?

Hydronidone is an investigational drug.

There have been 6 clinical trials for Hydronidone. The most recent clinical trial was a Phase 1 trial, which was initiated on November 20th 2021.

The most common disease conditions in clinical trials are Hepatitis B, Hepatitis, and Liver Cirrhosis. The leading clinical trial sponsors are Beijing Continent Pharmaceutical Co, Ltd., Shanghai Genomics, Inc., and [disabled in preview].

There are eighteen US patents protecting this investigational drug and one hundred and forty-nine international patents.

Recent Clinical Trials for Hydronidone
TitleSponsorPhase
Hydronidone for the Treatment of Liver Fibrosis Associated With Chronic Viral Hepatitis B Phase 3 Trial.Beijing Continent Pharmaceutical Co, Ltd.Phase 3
Study on Pharmacokinetics of HydronidoneBeijing Continent Pharmaceutical Co, Ltd.Phase 1
Study on PK of Hydronidone in Patients and Special PopulationBeijing Continent Pharmaceutical Co, Ltd.Phase 1

See all Hydronidone clinical trials

Clinical Trial Summary for Hydronidone

Top disease conditions for Hydronidone
Top clinical trial sponsors for Hydronidone

See all Hydronidone clinical trials

US Patents for Hydronidone

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Hydronidone See Plans and Pricing Method of modulating stress-activated protein kinase system INTERMUNE, INC. (Brisbane, CA) See Plans and Pricing
Hydronidone See Plans and Pricing Aerosol pirfenidone and pyridone analog compounds and uses thereof AVALYN PHARMA INC. (Seattle, CA) See Plans and Pricing
Hydronidone See Plans and Pricing Aerosol pirfenidone and pyridone analog compounds and uses thereof AVALYN PHARMA INC. (Seattle, WA) See Plans and Pricing
Hydronidone See Plans and Pricing Aerosol pirfenidone and pyridone analog compounds and uses thereof Avalyn Pharma Inc. (Seattle, WA) See Plans and Pricing
Hydronidone See Plans and Pricing Small molecule therapies for pulmonary hypertension Creighton University (Omaha, NE) See Plans and Pricing
Hydronidone See Plans and Pricing Aerosol pirfenidone and pyridone analog compounds and uses thereof AVALYN PHARMA INC. (Seattle, WA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Hydronidone

Drugname Country Document Number Estimated Expiration Related US Patent
Hydronidone Australia AU2006244072 2025-05-10 See Plans and Pricing
Hydronidone Brazil BRPI0608907 2025-05-10 See Plans and Pricing
Hydronidone Canada CA2608116 2025-05-10 See Plans and Pricing
Hydronidone China CN101237869 2025-05-10 See Plans and Pricing
Hydronidone China CN103012254 2025-05-10 See Plans and Pricing
Hydronidone Cyprus CY1115795 2025-05-10 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Merck
McKesson
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.